• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯并硼唑:致病细菌碳酸酐酶的新型强效抑制剂

Benzoxaboroles: New Potent Inhibitors of the Carbonic Anhydrases of the Pathogenic Bacterium .

作者信息

Bonardi Alessandro, Nocentini Alessio, Cadoni Roberta, Del Prete Sonia, Dumy Pascal, Capasso Clemente, Gratteri Paola, Supuran Claudiu T, Winum Jean-Yves

机构信息

Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, 50121 Florence, Italy.

Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, Laboratory of Molecular Modeling Cheminformatics & QSAR, University of Florence, 50121 Florence, Italy.

出版信息

ACS Med Chem Lett. 2020 Sep 9;11(11):2277-2284. doi: 10.1021/acsmedchemlett.0c00403. eCollection 2020 Nov 12.

DOI:10.1021/acsmedchemlett.0c00403
PMID:33214840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7667823/
Abstract

A series of urea/thiourea substituted benzoxaboroles was investigated for the inhibition of the three carbonic anhydrases encoded by (VchCAα, VchCAβ, and VchCAγ). In particular, benzoxaborole derivatives were here first assayed for the inhibition of a γ-class CA, extending the panel of CA classes that benzoxaboroles efficiently target beyond α and β. Inhibition profiles demonstrated that VchCAα was significantly more inhibited compared to VchCAγ and, in turn, more efficiently modulated than VchCAβ. Among the many selective benzoxaborole ligands detected against VchCAα over the off-target hCA II, compound , a -NO-phenylthiourea derivative, even exhibited a fully selective inhibition profile against the three VchCAs over hCA II. A comprehensive ligand/target interaction study was performed for all three VchCA isoforms providing the first molecular modeling investigation with inhibitors of a γ-class CA to the best of our knowledge. The present study reinforces the rationale behind the use of benzoxaboroles as innovative antibacterial agents with a new mechanism of action, furnishing suggestions for the rational design of new potent and selective inhibitors targeting CAs over human off-target ones.

摘要

研究了一系列尿素/硫脲取代的苯并硼氧六环对由(VchCAα、VchCAβ和VchCAγ)编码的三种碳酸酐酶的抑制作用。特别是,在此首次测定了苯并硼氧六环衍生物对γ类碳酸酐酶的抑制作用,从而将苯并硼氧六环有效靶向的碳酸酐酶类别扩展到α类和β类之外。抑制谱表明,与VchCAγ相比,VchCAα受到的抑制作用明显更强,进而比VchCAβ受到更有效的调节。在针对VchCAα检测到的众多对脱靶hCA II具有选择性的苯并硼氧六环配体中,化合物,一种-NO-苯基硫脲衍生物,甚至对三种VchCAs相对于hCA II表现出完全选择性的抑制谱。针对所有三种VchCA同工型进行了全面的配体/靶点相互作用研究,据我们所知,这是首次对γ类碳酸酐酶抑制剂进行分子建模研究。本研究强化了将苯并硼氧六环用作具有新作用机制的创新抗菌剂的基本原理,为合理设计针对碳酸酐酶而非人类脱靶酶的新型强效和选择性抑制剂提供了建议。

相似文献

1
Benzoxaboroles: New Potent Inhibitors of the Carbonic Anhydrases of the Pathogenic Bacterium .苯并硼唑:致病细菌碳酸酐酶的新型强效抑制剂
ACS Med Chem Lett. 2020 Sep 9;11(11):2277-2284. doi: 10.1021/acsmedchemlett.0c00403. eCollection 2020 Nov 12.
2
Antibacterial carbonic anhydrase inhibitors targeting enzymes.靶向酶的抗菌碳酸酐酶抑制剂。
Expert Opin Ther Targets. 2024 Jul;28(7):623-635. doi: 10.1080/14728222.2024.2369622. Epub 2024 Jul 19.
3
Seeking new approach for therapeutic treatment of cholera disease via inhibition of bacterial carbonic anhydrases: experimental and theoretical studies for sixteen benzenesulfonamide derivatives.寻求通过抑制细菌碳酸酐酶治疗霍乱病的新方法:十六个苯磺酰胺衍生物的实验和理论研究。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1186-1192. doi: 10.1080/14756366.2019.1618292.
4
Acyl selenoureido benzensulfonamides show potent inhibitory activity against carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.酰基硒脲基苯磺酰胺对来自致病性细菌霍乱弧菌的碳酸酐酶显示出强大的抑制活性。
Bioorg Chem. 2017 Dec;75:170-172. doi: 10.1016/j.bioorg.2017.09.016. Epub 2017 Sep 21.
5
Activation studies of the α- and β-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae with amines and amino acids.对致病性细菌霍乱弧菌的α-和β-碳酸酐酶与胺类和氨基酸的激活研究。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):227-233. doi: 10.1080/14756366.2017.1412316.
6
In Silico-Guided Identification of New Potent Inhibitors of Carbonic Anhydrases Expressed in .基于计算机辅助的在……中表达的碳酸酐酶新型强效抑制剂的鉴定
ACS Med Chem Lett. 2020 Sep 1;11(11):2294-2299. doi: 10.1021/acsmedchemlett.0c00417. eCollection 2020 Nov 12.
7
Inhibition of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium with aromatic sulphonamides and clinically licenced drugs - a joint docking/molecular dynamics study.用芳香族磺酰胺和临床许可药物对致病细菌的α-、β-和γ-碳酸酐酶进行抑制——一项联合对接/分子动力学研究。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):469-479. doi: 10.1080/14756366.2020.1862102.
8
Comparison of the sulfonamide inhibition profiles of the α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.霍乱弧菌致病细菌中α-、β-和γ-碳酸酐酶的磺胺类抑制谱比较。
Bioorg Med Chem Lett. 2016 Apr 15;26(8):1941-6. doi: 10.1016/j.bmcl.2016.03.014. Epub 2016 Mar 7.
9
Selenides bearing benzenesulfonamide show potent inhibition activity against carbonic anhydrases from pathogenic bacteria Vibrio cholerae and Burkholderia pseudomallei.硒化物负载苯磺酰胺对来自致病菌霍乱弧菌和类鼻疽伯克霍尔德菌的碳酸酐酶表现出很强的抑制活性。
Bioorg Chem. 2018 Sep;79:319-322. doi: 10.1016/j.bioorg.2018.05.015. Epub 2018 May 18.
10
Inhibition of α-, β-, γ-, and δ-carbonic anhydrases from bacteria and diatoms with N'-aryl-N-hydroxy-ureas.用 N'-芳基-N-羟基脲抑制细菌和硅藻中的 α-、β-、γ-和 δ-碳酸酐酶。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):1194-1198. doi: 10.1080/14756366.2018.1490733.

引用本文的文献

1
Exploring aliphatic sulfonamides as multiclass inhibitors of the carbonic anhydrases from the pathogen bacterium Vibrio cholerae.探索脂肪族磺酰胺作为霍乱弧菌碳酸酐酶多类抑制剂的作用。
Arch Pharm (Weinheim). 2025 Jan;358(1):e2400814. doi: 10.1002/ardp.202400814.
2
The carbonic anhydrase enzymes as new targets for the management of neglected tropical diseases.碳酸酐酶作为被忽视热带病治疗的新靶点。
Arch Pharm (Weinheim). 2025 Jan;358(1):e2400626. doi: 10.1002/ardp.202400626. Epub 2024 Nov 9.
3
Exploiting thiol-functionalized benzosiloxaboroles for achieving diverse substitution patterns - synthesis, characterization and biological evaluation of promising antibacterial agents.利用硫醇官能化苯并硅氧硼杂环戊烷实现多种取代模式——有前景的抗菌剂的合成、表征及生物学评价
RSC Med Chem. 2024 Mar 20;15(5):1751-1772. doi: 10.1039/d4md00061g. eCollection 2024 May 22.
4
Development of Penicillin-Based Carbonic Anhydrase Inhibitors Targeting Multidrug-Resistant .基于青霉素的碳酸酐酶抑制剂的开发,针对多药耐药。
J Med Chem. 2024 Jun 13;67(11):9613-9627. doi: 10.1021/acs.jmedchem.4c00740. Epub 2024 May 22.
5
Benzothiadiazinone-1,1-Dioxide Carbonic Anhydrase Inhibitors Suppress the Growth of Drug-Resistant Strains.苯并噻二嗪酮-1,1-二氧化物碳酸酐酶抑制剂可抑制耐药菌株的生长。
Int J Mol Sci. 2024 Feb 23;25(5):2584. doi: 10.3390/ijms25052584.
6
Inhibition Studies on Human and Mycobacterial Carbonic Anhydrases with -((4-Sulfamoylphenyl)carbamothioyl) Amides.-(4-磺酰胺基苯基)氨甲酰硫酰胺对人和分枝杆菌碳酸酐酶的抑制研究。
Molecules. 2023 May 11;28(10):4020. doi: 10.3390/molecules28104020.
7
Benzenesulfonamide derivatives as carbonic anhydrases inhibitors: a computational-aided insight in the structural rigidity-activity relationships.苯磺酰胺衍生物作为碳酸酐酶抑制剂:结构刚性-活性关系的计算辅助研究。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2201402. doi: 10.1080/14756366.2023.2201402.
8
Inhibition of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium with aromatic sulphonamides and clinically licenced drugs - a joint docking/molecular dynamics study.用芳香族磺酰胺和临床许可药物对致病细菌的α-、β-和γ-碳酸酐酶进行抑制——一项联合对接/分子动力学研究。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):469-479. doi: 10.1080/14756366.2020.1862102.

本文引用的文献

1
Exploring benzoxaborole derivatives as carbonic anhydrase inhibitors: a structural and computational analysis reveals their conformational variability as a tool to increase enzyme selectivity.探索苯并硼氧杂环丁烷衍生物作为碳酸酐酶抑制剂:结构和计算分析揭示其构象可变性作为提高酶选择性的工具。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1498-1505. doi: 10.1080/14756366.2019.1653291.
2
Bis-benzoxaboroles: Design, Synthesis, and Biological Evaluation as Carbonic Anhydrase Inhibitors.双苯并氧硼杂环戊烷:作为碳酸酐酶抑制剂的设计、合成及生物学评价
ACS Med Chem Lett. 2019 Jul 11;10(8):1205-1210. doi: 10.1021/acsmedchemlett.9b00252. eCollection 2019 Aug 8.
3
Epidemiology of cholera.霍乱流行病学
Vaccine. 2020 Feb 29;38 Suppl 1:A31-A40. doi: 10.1016/j.vaccine.2019.07.078. Epub 2019 Aug 5.
4
Antibiotic resistance in Vibrio cholerae: Understanding the ecology of resistance genes and mechanisms.霍乱弧菌的抗生素耐药性:耐药基因和机制的生态学研究。
Vaccine. 2020 Feb 29;38 Suppl 1:A83-A92. doi: 10.1016/j.vaccine.2019.06.031. Epub 2019 Jul 2.
5
Molecular Adaptations and Antibiotic Resistance in : A Communal Challenge.在 : 共同面临的挑战中,分子适应和抗生素耐药性。
Microb Drug Resist. 2019 Sep;25(7):1012-1022. doi: 10.1089/mdr.2018.0354. Epub 2019 Apr 25.
6
Molecular structure of thermostable and zinc-ion-binding γ-class carbonic anhydrases.热稳定和锌离子结合的 γ 类碳酸酐酶的分子结构。
Biometals. 2019 Apr;32(2):317-328. doi: 10.1007/s10534-019-00190-8. Epub 2019 Mar 20.
7
Cholera: recent updates.霍乱:最新进展。
Curr Opin Infect Dis. 2018 Oct;31(5):455-461. doi: 10.1097/QCO.0000000000000474.
8
Vibrio spp. infections.弧菌属感染。
Nat Rev Dis Primers. 2018 Jul 12;4(1):8. doi: 10.1038/s41572-018-0005-8.
9
Biomedical applications of prokaryotic carbonic anhydrases.原核碳酸酐酶的生物医学应用。
Expert Opin Ther Pat. 2018 Oct;28(10):745-754. doi: 10.1080/13543776.2018.1497161. Epub 2018 Jul 16.
10
Benzoxaborole compounds for therapeutic uses: a patent review (2010- 2018).苯并硼唑类化合物在治疗用途中的应用:专利审查(2010-2018 年)。
Expert Opin Ther Pat. 2018 Jun;28(6):493-504. doi: 10.1080/13543776.2018.1473379. Epub 2018 May 11.